NCT06310811View on ClinicalTrials.gov

Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2027

Conditions
SafetyEffective
Interventions
DRUG

RD06-04 Cells injection

Patient will be treated with RD06-04 cells when enrolled in the study

Trial Locations (1)

430000

RECRUITING

Wuhan Union, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER